GAB GABELLI EQUITY TRUST INC

NEUTRAL Impact: 4/10 8-K
Horizon weeks Filed May 7, 2026 Processed 1mo ago SEC 0001829126-26-004782
8-K context-dependent: Items 8.01
Latest settled — T+20d
GAB-PK ▼ -2.48% at T+20d
NEUTRAL call ✗ call lost -2.48% · α vs SPY -2.51% · entry $20.54 → $20.03
Next anchor: T+60d in 7w
Currently $5.65 · -72.49% from $20.54 entry
Entry anchored
May 7, 2026
via day open
T+1d
+0.49%
call +0.49% · α +0.25%
$20.64
settled 5w ago
T+5d
+0.05%
call +0.05% · α -1.42%
$20.55
settled 4w ago
T+20d
-2.48%
call -2.48% · α -2.51%
$20.03
settled 8d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

The Fund disclosed that Mario J. Gabelli, its Chairman and Chief Investment Officer, was hospitalized on March 19, 2026, after a medical incident. His condition is improving but his return timeline is unknown. GAMCO has activated its succession plan, with Christopher J. Marangi named President and co-leading the portfolio management team alongside Kevin V. Dreyer during Mr. Gabelli's absence. This is a key-person event for a fund heavily associated with its founder, but the succession plan appears orderly.

Actionable Insight

Monitor for any subsequent filings indicating a change in Mr. Gabelli's status or any material impact on fund performance or asset flows. The orderly succession plan reduces near-term disruption risk, but the fund's long-term association with its founder means any prolonged absence could affect investor sentiment.

Key Facts

  • Mario J. Gabelli was hospitalized on March 19, 2026, after a medical incident.
  • His condition is improving but the timeline for his return is not yet known.
  • GAMCO implemented its pre-existing succession plan on March 22, 2026.
  • Christopher J. Marangi was named President of GAMCO on March 22, 2026.
  • Day-to-day operations continue to be led by co-CEO Douglas R. Jamieson and Christopher J. Marangi.
  • Kevin V. Dreyer and Christopher J. Marangi lead the portfolio management team for the Fund during Mr. Gabelli's absence.

Financial Impact

No financial figures disclosed. The event is operational/succession-related with no immediate quantifiable financial impact.

Risk Factors

  • Prolonged absence of Mario Gabelli could negatively impact investor confidence and fund flows.
  • Uncertainty around the founder's return timeline may create overhang on the fund's securities.
  • Succession plan execution may face unforeseen challenges if Mr. Gabelli's recovery is delayed.

Market Snapshot

Exchange
NYSE

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001829126-26-004782
Document: 0001829126-26-004782-index-headers.html0001829126-26-004782
Document: 0001829126-26-004782-index.html0001829126-26-004782
Document: 0001829126-26-004782.txt0001829126-26-004782
2 reports for GAB
Performance horizon
Filters
Rows
Reports for GAB — sortable, filterable
Type Now
May 13, 2026
4w ago
Press Release
NEUTRAL ★ 2/10
$5.59 $5.54▼ −0.89%▲ +0.26%$5.65 (+1.07%)
May 7, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$20.54 $20.55▲ +0.05%▼ −1.42%$5.65 (−72.49%)
Showing 2 of 2

US Market Status

Market Closed — Opens Mon (48h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access